CVE-2018-10593
A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to…
Does this matter?
Lower severity and a low EPSS score (0.36%). Track it; it rarely justifies an emergency change on its own.
Description
A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in data corruption.
- CVSS 3.0
- 5.6 MEDIUMCVSS:3.0/AV:A/AC:H/PR:H/UI:R/S:U/C:N/I:H/A:H
- EPSS
- 0.36% probability · 30th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-356, CWE-89
- Affected
- bd/database manager · bd/performa · bd/reada
- Source
- ics-cert@hq.dhs.gov
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01Third Party Advisory, US Government Resource
- https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqulaVendor Advisory
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01Third Party Advisory, US Government Resource
- https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqulaVendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.